We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$918M
AUM Growth
-$131M
Cap. Flow
-$175M
Cap. Flow %
-19.06%
Top 10 Hldgs %
16.38%
Holding
1,902
New
267
Increased
673
Reduced
501
Closed
283

Sector Composition

Rank Sector Weight
1 Financials 15.47%
2 Technology 14.63%
3 Healthcare 10.78%
4 Consumer Discretionary 10.41%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFC
1301
DELISTED
Entegra Financial Corp.
ENFC
$5K ﹤0.01%
+200
New +$4.65K
EGLT
1302
DELISTED
Egalet Corporation
EGLT
$5K ﹤0.01%
4,091
+3,728
+1,027% +$4.99K
TAX
1303
DELISTED
Liberty Tax, Inc. Class A
TAX
$5K ﹤0.01%
377
KND
1304
DELISTED
Kindred Healthcare
KND
$5K ﹤0.01%
746
-37
-5% -$315
HDNG
1305
DELISTED
Hardinge Inc
HDNG
$5K ﹤0.01%
+347
New +$4.67K
WIN
1306
DELISTED
Windstream Holdings Inc
WIN
$5K ﹤0.01%
558
+219
+65% +$2.9K
WLB
1307
DELISTED
Westmoreland Coal Company
WLB
$5K ﹤0.01%
2,148
+812
+61% +$2.52K
EXA
1308
DELISTED
EXA Corporation
EXA
$5K ﹤0.01%
218
BBOX
1309
DELISTED
Black Box Corp
BBOX
$5K ﹤0.01%
1,508
+231
+18% +$1.24K
APVO icon
1310
Aptevo Therapeutics
APVO
$5.07M
0
ARCB icon
1311
ArcBest
ARCB
$3.02B
$4K ﹤0.01%
120
+52
+76% +$1.37K
BFIN
1312
DELISTED
BankFinancial
BFIN
$4K ﹤0.01%
278
BLUE
1313
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
2
BMRC icon
1314
Bank of Marin Bancorp
BMRC
$465M
$4K ﹤0.01%
130
+68
+110% +$2.21K
CZNC icon
1315
Citizens & Northern Corp
CZNC
$453M
$4K ﹤0.01%
183
DDS icon
1316
Dillards
DDS
$9.64B
$4K ﹤0.01%
+67
New +$4.13K
FOLD
1317
DELISTED
Amicus Therapeutics
FOLD
$4K ﹤0.01%
+271
New +$3.58K
HNRG icon
1318
Hallador Energy
HNRG
$698M
$4K ﹤0.01%
+728
New +$4.72K
HPP
1319
Hudson Pacific Properties
HPP
$729M
$4K ﹤0.01%
18
INO icon
1320
Inovio Pharmaceuticals
INO
$69.6M
$4K ﹤0.01%
58
-49
-46% -$3.65K
JOUT icon
1321
Johnson Outdoors
JOUT
$498M
$4K ﹤0.01%
+51
New +$2.97K
LGND icon
1322
Ligand Pharmaceuticals
LGND
$6.02B
$4K ﹤0.01%
+45
New +$3.56K
NERV icon
1323
Minerva Neurosciences
NERV
$207M
$4K ﹤0.01%
60
NHTC icon
1324
Natural Health Trends
NHTC
$14.5M
$4K ﹤0.01%
165
-9
-5% -$205
NTLA icon
1325
Intellia Therapeutics
NTLA
$1.57B
$4K ﹤0.01%
169
-149
-47% -$2.81K

Similar funds

Meeder Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Meeder Asset Management held 1,902 positions worth $918M, down 12% from $1.05B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Meeder Asset Management withdrew a net $175M in Q3 2017, closing 283 positions and reducing 501 holdings. Its most notable exit was Altria Group, an estimated $4.49M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Meeder Asset Management opened a new position in RTX Corp worth $2.6M.

  • Meeder Asset Management's largest Q3 2017 buy was RTX Corp: 35,540 shares worth $2.6M.
  • Meeder Asset Management added most to Bank of New York Mellon in Q3 2017, an estimated $5.83M increase.
  • Meeder Asset Management's biggest Q3 2017 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $46.1M.
  • Meeder Asset Management fully exited Altria Group in Q3 2017, selling an estimated $4.49M.
  • Meeder Asset Management's ten largest holdings make up 16% of its $918M portfolio in Q3 2017.
  • Meeder Asset Management opened 267 new positions and closed 283 in Q3 2017.
  • Meeder Asset Management's portfolio value fell 12% quarter-over-quarter to $918M.

Based on Meeder Asset Management's 13F filing for Q3 2017, filed 20 Oct 2017.